Ando Y, Fuse E, Figg WD (1. 6. 2002). „Thalidomide metabolism by the CYP2C subfamily”. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8 (6): 1964—73. PMID12060642. Приступљено 18. 6. 2009.
Rao, KV (2007). „Lenalidomide in the treatment of multiple myeloma”. American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists. 64 (17): 1799—807. PMID17724360. doi:10.2146/ajhp070029.
Ando Y, Fuse E, Figg WD (1. 6. 2002). „Thalidomide metabolism by the CYP2C subfamily”. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8 (6): 1964—73. PMID12060642. Приступљено 18. 6. 2009.
Rao, KV (2007). „Lenalidomide in the treatment of multiple myeloma”. American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists. 64 (17): 1799—807. PMID17724360. doi:10.2146/ajhp070029.
timesonline.co.uk
Bowditch, Gillian (26. 3. 2006). „Can thalidomide ever be trusted?”. The Sunday Times. News International Limited. Приступљено 1. 5. 2009.